Literature DB >> 21073664

Prediction and prevention of Type 1 diabetes mellitus.

Li Zhang1, George S Eisenbarth.   

Abstract

Type 1A diabetes mellitus (T1DM) is caused by autoimmune islet β-cell destruction with consequent severe insulin deficiency. We can now predict the development of T1DM by determining four biochemically characterized islet autoantibodies, namely those antibodies against insulin, glutamic acid decarboxylase 65, insulinoma antigen (IA)-2 (ICA512) and the zinc transporter ZnT8. We can also prevent T1DM in animal models, but the final goal is the prevention of T1DM in humans. Multiple clinical trials are underway investigating methods to prevent β-cell destruction.
© 2011 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21073664     DOI: 10.1111/j.1753-0407.2010.00102.x

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  27 in total

1.  Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.

Authors:  L I Alves; E Davini; M R Correia; R T Fukui; R F Santos; M R Cunha; D M Rocha; W M G Volpini; M E R Silva
Journal:  J Clin Immunol       Date:  2012-03-09       Impact factor: 8.317

2.  Novel autoantigens in type 1 diabetes.

Authors:  Shuhong Han; William Donelan; Hai Wang; Westley Reeves; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

3.  Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes.

Authors:  Jamie L Felton; Damian Maseda; Rachel H Bonami; Chrys Hulbert; James W Thomas
Journal:  J Immunol       Date:  2018-06-27       Impact factor: 5.422

4.  Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.

Authors:  M Andrade Lima Gabbay; M N Sato; A J S Duarte; S A Dib
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 5.  Synthetic Morphogenesis.

Authors:  Brian P Teague; Patrick Guye; Ron Weiss
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

Review 6.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

7.  Antibodies to post-translationally modified insulin in type 1 diabetes.

Authors:  Rocky Strollo; Chiara Vinci; Mayda H Arshad; David Perrett; Claudio Tiberti; Francesco Chiarelli; Nicola Napoli; Paolo Pozzilli; Ahuva Nissim
Journal:  Diabetologia       Date:  2015-09-08       Impact factor: 10.122

8.  Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.

Authors:  A S B Wolff; A K Sarkadi; L Maródi; J Kärner; E Orlova; B E V Oftedal; K Kisand; E Oláh; A Meloni; A G Myhre; E S Husebye; R Motaghedi; J Perheentupa; P Peterson; N Willcox; A Meager
Journal:  J Clin Immunol       Date:  2013-10-26       Impact factor: 8.317

Review 9.  Immune-mediated β-cell death in type 1 diabetes: lessons from human β-cell lines.

Authors:  Yaíma L Lightfoot; Jing Chen; Clayton E Mathews
Journal:  Eur J Clin Invest       Date:  2012-08-25       Impact factor: 4.686

10.  CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.

Authors:  Jeffrey D Price; Nicole M Beauchamp; Gwendoline Rahir; Yongge Zhao; Cosima C Rieger; Annie W Lau-Kilby; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2013-09-30       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.